Issue 2/2012
Content (26 Articles)
E-cadherin as a predictive marker of brain metastasis in non-small-cell lung cancer, and its regulation by pioglitazone in a preclinical model
Jin Young Yoo, Seung-Ho Yang, Jung Eun Lee, Deog Gon Cho, Hoon Kyo Kim, Sung Hwan Kim, Il Sup Kim, Jae Taek Hong, Jae Hoon Sung, Byung Chul Son, Sang Won Lee
Intracerebral infusion of the bispecific targeted toxin DTATEGF in a mouse xenograft model of a human metastatic non-small cell lung cancer
Jun Huang, Yan Michael Li, Joan Massague, Andy Sicheneder, Daniel A. Vallera, Walter A. Hall
MicroRNAs in cerebrospinal fluid as biomarker for disease course monitoring in primary central nervous system lymphoma
Alexander Baraniskin, Jan Kuhnhenn, Uwe Schlegel, Wolf Schmiegel, Stephan Hahn, Roland Schroers
Isthmin inhibits glioma growth through antiangiogenesis in vivo
Bangqing Yuan, Ronghua Xian, Jianfang Ma, Yujian Chen, Chuangan Lin, Yaoming Song
IDH1 mutations inhibit multiple α-ketoglutarate-dependent dioxygenase activities in astroglioma
Ying Liu, Wenqing Jiang, Jing Liu, Shimin Zhao, Ji Xiong, Ying Mao, Yin Wang
Genetic characterization of gliomas arising in patients with multiple sclerosis
Adam Khalil, Hilary Serracino, Denise M. Damek, Douglas Ney, Kevin O. Lillehei, B. K. Kleinschmidt-DeMasters
Stereotactic iodine-125 brachytherapy for treatment of inoperable focal brainstem gliomas of WHO grades I and II: feasibility and long-term outcome
Maximilian I. Ruge, Philipp Kickingereder, Thorsten Simon, Harald Treuer, Volker Sturm
Rituximab significantly improves complete response rate in patients with primary CNS lymphoma
Tobias Birnbaum, Elisabeth Anne Stadler, Louisa von Baumgarten, Andreas Straube
Leptomeningeal seeding in patients with brain metastases treated by gamma knife radiosurgery
Kyung-Il Jo, Do-Hoon Lim, Sung-Tae Kim, Yong-Seok Im, Doo Sik Kong, Ho Jun Seol, Do-Hyun Nam, Jung-Il Lee
Population-based survival data for brain tumors in Korea
Kyu-Won Jung, Heon Yoo, Hyun-Joo Kong, Young-Joo Won, Sohee Park, Seung Hoon Lee
Primary tumor response to chemoradiotherapy in limited-disease small-cell lung cancer correlates with duration of brain-metastasis free survival
Farkhad Manapov, Sabine Klöcking, Maximilian Niyazi, Victor Levitskiy, Claus Belka, Guido Hildebrandt, Rainer Fietkau, Gunther Klautke
Potential risk factors for incident glioblastoma multiforme: the Honolulu Heart Program and Honolulu-Asia Aging Study
James S. Nelson, Cecil M. Burchfiel, Desta Fekedulegn, Michael E. Andrew
Imatinib mesylate treatment of recurrent meningiomas in preselected patients: a retrospective analysis
Peter Horak, Adelheid Wöhrer, Marco Hassler, Johannes Hainfellner, Matthias Preusser, Christine Marosi
Neurocognitive and sociodemographic functioning of glioblastoma long-term survivors
Birgit Flechl, Michael Ackerl, Cornelia Sax, Karin Dieckmann, Richard Crevenna, Alexander Gaiger, Georg Widhalm, Matthias Preusser, Christine Marosi
Resection of gliomas in the cingulate gyrus: functional outcome and survival
Ági Oszvald, Johanna Quick, Kea Franz, Erdem Güresir, Andrea Szelényi, Hartmut Vatter, Volker Seifert
Transient enlargement of craniopharyngioma after radiation therapy: pattern of magnetic resonance imaging response following radiation
Zheng Shi, Natia Esiashvili, Anna J. Janss, Claire M. Mazewski, Tobey J. MacDonald, David M. Wrubel, Barunashish Brahma, Frederick P. Schwaibold, Robert B. Marcus, Ian R. Crocker, Hui-Kuo G. Shu
Phase II study of Ginkgo biloba in irradiated brain tumor patients: effect on cognitive function, quality of life, and mood
Albert Attia, Stephen R. Rapp, L. Doug Case, Ralph D’Agostino, Glenn Lesser, Michelle Naughton, Kevin McMullen, Robin Rosdhal, Edward G. Shaw
Intracavitary brachytherapy using stereotactically applied phosphorus-32 colloid for treatment of cystic craniopharyngiomas in 53 patients
Philipp Kickingereder, Mohammad Maarouf, Faycal El Majdoub, Manuel Fuetsch, Ralph Lehrke, Jochen Wirths, Klaus Luyken, Klaus Schomaecker, Harald Treuer, Juergen Voges, Volker Sturm
Successful treatment with a low-dose cisplatin–etoposide regimen for patients with diencephalic syndrome
Iacopo Sardi, Cecilia Bresci, Elisabetta Schiavello, Veronica Biassoni, Valentina Fratoni, Stefania Cardellicchio, Lorenzo Genitori, Maurizio Aricò, Maura Massimino
Temozolomide or bevacizumab for spinal cord high-grade gliomas
Thomas J. Kaley, Ijah Mondesire-Crump, Igor T. Gavrilovic
Radiotherapy and concomitant temozolomide may improve survival of elderly patients with glioblastoma
Christopher A. Barker, Maria Chang, Joanne F. Chou, Zhigang Zhang, Kathryn Beal, Philip H. Gutin, Fabio M. Iwamoto
Fatty acid synthase is a predictive marker for aggressiveness in meningiomas
Keishi Makino, Hideo Nakamura, Taku-ichiro Hide, Shigetoshi Yano, Jun-ichiro Kuroda, Ken-ichi Iyama, Jun-ichi Kuratsu
Identification of a novel population in high-grade oligodendroglial tumors not deleted on 1p/19q using array CGH
Matthieu Talagas, Pascale Marcorelles, Arnaud Uguen, Sylvia Redon, Isabelle Quintin-Roué, Sebastian Costa, Claude Férec, Frédéric Morel, Phong Dam Hieu, Marc De Braekeleer
DNA copy number alterations in central primitive neuroectodermal tumors and tumors of the pineal region: an international individual patient data meta-analysis
André O. von Bueren, Joachim Gerss, Christian Hagel, Haoyang Cai, Marc Remke, Martin Hasselblatt, Burt G. Feuerstein, Sarah Pernet, Olivier Delattre, Andrey Korshunov, Stefan Rutkowski, Stefan M. Pfister, Michael Baudis
Outcomes of hypofractionated stereotactic radiotherapy for metastatic brain tumors with high risk factors
Kengo Ogura, Takashi Mizowaki, Masakazu Ogura, Katsuyuki Sakanaka, Yoshiki Arakawa, Susumu Miyamoto, Masahiro Hiraoka
Procarbazine, carmustine, and vincristine (PBV) for chemotherapy pre-treated patients with recurrent glioblastoma: a single-institution analysis
Jan Kuhnhenn, Thomas Kowalski, Sabine Steenken, Kathrin Ostermann, Uwe Schlegel